目的:建立药用丁基橡胶塞中添加剂[抗氧剂264(2,6-二叔丁基-4-甲基苯酚,简称BHT)和硫化剂可提取硫]的含量测定方法。方法:以二氯甲烷-无水乙醇为提取溶剂,利用高效液相色谱法对药用丁基橡胶塞的BHT和可提取硫含量进行测定,以含0.1%三氟...目的:建立药用丁基橡胶塞中添加剂[抗氧剂264(2,6-二叔丁基-4-甲基苯酚,简称BHT)和硫化剂可提取硫]的含量测定方法。方法:以二氯甲烷-无水乙醇为提取溶剂,利用高效液相色谱法对药用丁基橡胶塞的BHT和可提取硫含量进行测定,以含0.1%三氟乙酸的乙腈-含0.1%三氟乙酸的水(90∶10)为流动相,流速1.0 m L·min^(-1),检测波长280 nm。结果:抗氧剂BHT的线性检测范围0.41~103.00μg·mL^(-1)(r^2=1.000),可提取硫的线性检测范围0.10~103.50μg·mL^(-1)(r^2=0.999 9),BHT和可提取硫的平均回收率分别为95.2%和86.8%。测定7批药用胶塞中BHT与可提取硫含量范围分别为4~206μg·g^(-1)和1~143μg·g^(-1)。结论:本文建立的检测方法经方法学验证,可用于考察药用丁基橡胶塞中BHT和可提取硫的含量及质量控制。展开更多
Background:Licochalcone A(LCA)is a flavonoid derived from the roots of Glycyrrhiza uralensis Fisch.ex DC and other related plants.Its natural source has been extensively used in complementary medicine,especially tradi...Background:Licochalcone A(LCA)is a flavonoid derived from the roots of Glycyrrhiza uralensis Fisch.ex DC and other related plants.Its natural source has been extensively used in complementary medicine,especially traditional Chinese medicine,to treat various ailments.Identified as a phenolic chalcone compound,LCA has gained significant attention in recent years due to its various pharmacological properties.Objective:The objective of this review article is to assess the anti-aging ralated pharmacological properties of LCA.Method:An exhaustive search of several scientific databases was conducted using various relevant keywords to write this review article on LCA,focusing on its therapeutic applications and anti-aging-related pharmacological activities.Some inclusion and exclusion criteria were strictly followed to retrieve updated relevant articles.Results:A collection of 292 papers were screened,and 131 were included in this review for an in-depth analysis of Licochalcone A,focusing on its anti-aging-related pharmacological activities and relevant mechanisms,and its toxicity and side effects.Moreover,the potential of LCA as a pharmacological product is discussed,emphasizing its health benefits and potential as a pharmaceutical product.Conclusion:These findings indicate that Licochalcone A is a promising natural therapeutic agent for anti-aging therapy and other ailments.展开更多
Intervertebral disc degeneration(IVDD)is commonly caused by imbalanced oxygen metabolism-triggered inflammation.Overcoming the shortcomings of antioxidants in IVDD treatment,including instability and the lack of targe...Intervertebral disc degeneration(IVDD)is commonly caused by imbalanced oxygen metabolism-triggered inflammation.Overcoming the shortcomings of antioxidants in IVDD treatment,including instability and the lack of targeting,remains challenging.Microfluidic and surface modification technologies were combined to graft chitosan nanoparticles encapsulated with strong reductive black phosphorus quantum dots(BPQDs)onto GelMA microspheres via amide bonds to construct oxygen metabolism-balanced engineered hydrogel microspheres(GM@CS-BP),which attenuate extracellular acidosis in nucleus pulposus(NP),block the inflammatory cascade,reduce matrix metalloproteinase expression(MMP),and remodel the extracellular matrix(ECM)in intervertebral discs(IVDs).The GM@CS-BP microspheres reduce H_(2)O_(2) intensity by 229%.Chemical grafting and electrostatic attraction increase the encapsulation rate of BPQDs by 167%and maintain stable release for 21 days,demonstrating the antioxidant properties and sustained modulation of the BPQDs.After the GM@CS-BP treatment,western blotting revealed decreased acid-sensitive ion channel-3 and inflammatory factors.Histological staining in an 8-week IVDD model confirmed the regeneration of NP.GM@CS-BP microspheres therefore maintain a balance between ECM synthesis and degradation by regulating the positive feedback between imbalanced oxygen metabolism in IVDs and inflammation.This study provides an in-depth interpretation of the mechanisms underlying the antioxidation of BPQDs and a new approach for IVDD treatment.展开更多
文摘目的:建立药用丁基橡胶塞中添加剂[抗氧剂264(2,6-二叔丁基-4-甲基苯酚,简称BHT)和硫化剂可提取硫]的含量测定方法。方法:以二氯甲烷-无水乙醇为提取溶剂,利用高效液相色谱法对药用丁基橡胶塞的BHT和可提取硫含量进行测定,以含0.1%三氟乙酸的乙腈-含0.1%三氟乙酸的水(90∶10)为流动相,流速1.0 m L·min^(-1),检测波长280 nm。结果:抗氧剂BHT的线性检测范围0.41~103.00μg·mL^(-1)(r^2=1.000),可提取硫的线性检测范围0.10~103.50μg·mL^(-1)(r^2=0.999 9),BHT和可提取硫的平均回收率分别为95.2%和86.8%。测定7批药用胶塞中BHT与可提取硫含量范围分别为4~206μg·g^(-1)和1~143μg·g^(-1)。结论:本文建立的检测方法经方法学验证,可用于考察药用丁基橡胶塞中BHT和可提取硫的含量及质量控制。
文摘Background:Licochalcone A(LCA)is a flavonoid derived from the roots of Glycyrrhiza uralensis Fisch.ex DC and other related plants.Its natural source has been extensively used in complementary medicine,especially traditional Chinese medicine,to treat various ailments.Identified as a phenolic chalcone compound,LCA has gained significant attention in recent years due to its various pharmacological properties.Objective:The objective of this review article is to assess the anti-aging ralated pharmacological properties of LCA.Method:An exhaustive search of several scientific databases was conducted using various relevant keywords to write this review article on LCA,focusing on its therapeutic applications and anti-aging-related pharmacological activities.Some inclusion and exclusion criteria were strictly followed to retrieve updated relevant articles.Results:A collection of 292 papers were screened,and 131 were included in this review for an in-depth analysis of Licochalcone A,focusing on its anti-aging-related pharmacological activities and relevant mechanisms,and its toxicity and side effects.Moreover,the potential of LCA as a pharmacological product is discussed,emphasizing its health benefits and potential as a pharmaceutical product.Conclusion:These findings indicate that Licochalcone A is a promising natural therapeutic agent for anti-aging therapy and other ailments.
基金supported by the National Natural Science Foundation of China(81972078,82120108017,82072438,82102589,81702190)Social Development Project of Jiangsu Province(BE2021646),Standardized Diagnosis and Treatment Project of Key Diseases in Jiangsu Province(BE2015641)+3 种基金the Natural Science Foundation of Jiangsu Province(BK20211504 and BK20170370)Suzhou Gusu Health Talent Program(GSWS2020001 and GSWS2021007)Jiangsu Innovative and Entrepreneurial Talent Program(JSSCBS20211570)Medical Health Science and Technology Innovation Program of Suzhou(SKY2022119).
文摘Intervertebral disc degeneration(IVDD)is commonly caused by imbalanced oxygen metabolism-triggered inflammation.Overcoming the shortcomings of antioxidants in IVDD treatment,including instability and the lack of targeting,remains challenging.Microfluidic and surface modification technologies were combined to graft chitosan nanoparticles encapsulated with strong reductive black phosphorus quantum dots(BPQDs)onto GelMA microspheres via amide bonds to construct oxygen metabolism-balanced engineered hydrogel microspheres(GM@CS-BP),which attenuate extracellular acidosis in nucleus pulposus(NP),block the inflammatory cascade,reduce matrix metalloproteinase expression(MMP),and remodel the extracellular matrix(ECM)in intervertebral discs(IVDs).The GM@CS-BP microspheres reduce H_(2)O_(2) intensity by 229%.Chemical grafting and electrostatic attraction increase the encapsulation rate of BPQDs by 167%and maintain stable release for 21 days,demonstrating the antioxidant properties and sustained modulation of the BPQDs.After the GM@CS-BP treatment,western blotting revealed decreased acid-sensitive ion channel-3 and inflammatory factors.Histological staining in an 8-week IVDD model confirmed the regeneration of NP.GM@CS-BP microspheres therefore maintain a balance between ECM synthesis and degradation by regulating the positive feedback between imbalanced oxygen metabolism in IVDs and inflammation.This study provides an in-depth interpretation of the mechanisms underlying the antioxidation of BPQDs and a new approach for IVDD treatment.
